NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled
NCT01125800 2017-03-20A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MBNovartisPhase 1/2 Completed76 enrolled 18 charts